Update: Clover Health Expects Average Number of Direct Contracting Lives in 2022 to Double from Current Levels

NEXT STORY
Senti Bio Highlights Colorectal Cancer Preclinical Data from Logic Gated CAR-NK Cell Program at 36th SITC Annual Meeting
PREV STORY
Celularity Reports Third Quarter 2021 Financial Results and Corporate Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Reata Pharmaceuticals, Inc. Appoints Geoffrey A. Block, M.D. as Vice President, Nephrology

author_avatar
NASDAQ Market News

Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies

author_avatar
NASDAQ Market News

Stemline Therapeutics Announces Presentation of ELZONRIS (tagraxofusp) Preclinical Data in Systemic Sclerosis, an Autoimmune Disorder, at EULAR Congress

author_avatar
NASDAQ Market News